The incidence and risk elevation of incident mental disorders in cancer patients vary based on sex, cancer type, time since diagnosis and type of mental disorder.
Searching for Solutions
Referring patients to behavioral health specialists for CBT and/or prescribing recommended pharmacotherapy with Collaborative Care Management can help to reduce patient morbidity and improve functioning.
These data indicate a need to identify and disseminate successful hospital-based strategies to increase prescribing of MAUD.
The link between specialty-care-only policies and lower diversion and overdose risk is not supported by the reviewed literature.
Actigraphy appears to be a feasible objective tool for sleep assessment in SUDs, though additional studies across diverse substances are needed.
Interactive sVMs can effectively dispense HR items and connect individuals to services, thereby having the potential to improve individual and public health. Contextual factors, such as location, may influence utilization.
Single-item patient-reported outcome measures are pragmatic tools for implementing measurement-based care in substance use treatment.
Symptom-based dosing decreased time to medical readiness for discharge compared with a scheduled opioid taper approach among infants cared for with ESC.
These results demonstrate substantial missed opportunities for MOUD treatment during pregnancy, highlighting the need for targeted interventions to improve evidence-based perinatal OUD care.
This cross-sectional study found a substantial increase in the percentage of individuals with OUD who received MOUD among almost all states.
Medicaid managed care plans located in Republican-leaning states were less likely to be subject to state requirements governing coverage and prior authorization of SUD treatment medications, with the exception of methadone, and were also less likely to align with requirements when imposed by states.
Orphines are 10 times more dangerous than fentanyl and are showing up in street drugs within the US.
This study evaluated the efficacy of semaglutide once-weekly in treatment-seeking patients with alcohol use disorder and comorbid obesity.
This report examines how existing CIC programs operate, funding strategies used to sustain their work and offers insights to help strengthen and expand CIC models nationwide.
In this large population based cohort, prenatal exposure to benzodiazepines or Z-hypnotics was not associated with an increased risk of psychiatric disorders in offspring.
The U.S. Department of Health and Human Services (HHS) recently announced efforts to curb psychiatric overprescribing at a MAHA Institute summit on mental health and overmedicalization.
No summary available
This article highlights state-level progress toward pharmacist reimbursement since the 2024 manuscript on this topic. A special thanks to the many AAPP members who assisted in the research and authorship of this manuscript which highlights expansion of pharmacist test-and-treat authority, new commercial coverage mandates, explicit Medicaid provider enrollment and reimbursement structures, and broadened scope-of-practice provisions tied to payment.
No summary available
No summary available
This systematic review and meta-analysis indicated a small association between antidepressants and ADHD or ASD.
CMS has formally acknowledged and encouraged the involvement of clinical pharmacists in medication management and deprescribing activities through team-based care models. In newly released billing guidance tied to Deprescribing Services Codes, CMS confirmed that pharmacists can contribute billable time through “incident-to” services provided under physician or non-physician practitioner collaborations.
This study provides key insights into the resource/cost requirements for implementing and sustaining each A.S.K.-PrEP strategy.
Police stop-and-search was associated with elevated subsequent overdose risk among PWUD.
In this trial of healthy adults who co-used cannabis and alcohol, cannabis edibles combined with alcohol augmented driving impairment.